EP4061358

ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    20.11.2020
  • EP published:
    28.5.2025
  • EP application number:
    20888950.1
  • Max expiry date:
    19.11.2040
  • Title in English:
    ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
  • Language of the patent:
    English

Timeline

Today
20.11.2020EP application
28.5.2025EP Publication

Owner

  • Name:
    Arena Pharmaceuticals, Inc.
  • Address:
    66 Hudson Boulevard East, New York, NY 10001-2192, US

Inventor

  • Name:
    KOMORI-OCCHICONE, Heather, Kiyomi
  • Address:
    San Diego, CA 92129, US
  • Name:
    NGUYEN-CLEARY, Thai, Curtis
  • Address:
    Carlsbad, CA 92009, US
  • Name:
    YU, Jin
  • Address:
    Tuscon, AZ 85045, US

Priority

  • Number:
    201962938008 P
  • Date:
    20.11.2019
  • Country:
    US

Classification

  • Categories:
    A61K 31/403, A61P 1/00, A61P 1/04, C07D 209/94, A61K 31/404, A61K 9/20

Upload documents